CC05 - Minimizing Risk of Hypoglycemia with Daily Glucose Management in Diverse Populations

Speaker(s)

• 

  Alice YY Cheng, Asoociate Professor (she/her/hers)

  Dr. Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and an Associat
  University of Toronto
  University of Toronto
  Toronto, Ontario, Canada

  Disclosure(s): Abbott Diabetes: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Amgen: Speaker/Honoraria (Ongoing); Astra Zeneca: Speaker/Honoraria (Ongoing); Bayer Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly & Company: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); GlaxoSmithKline: Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Insulet: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Advisory Board (Ongoing); Medtronic: Speaker/Honoraria (Ongoing); Novo Nordisk A/S: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk Canada Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Speaker/Honoraria (Ongoing); Sanofi: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing)